Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Filters applied: . Clear all
Page 1
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Mehra MR, Desai SS, Ruschitzka F, Patel AN. Mehra MR, et al. Lancet. 2020 May 22:S0140-6736(20)31180-6. doi: 10.1016/S0140-6736(20)31180-6. Online ahead of print. Lancet. 2020. PMID: 32450107 Free PMC article. Retracted.
METHODS: We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. ...We included patients hospitalised between Dec 20, 2019, and April 14, 2020, with a …
METHODS: We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macroli
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
Sun J, Chen Y, Fan X, Wang X, Han Q, Liu Z. Sun J, et al. Postgrad Med. 2020 Jun 21:1-10. doi: 10.1080/00325481.2020.1778982. Online ahead of print. Postgrad Med. 2020. PMID: 32496926
Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading worldwide. Antiviral therapy is the most important treatment for
Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Nina PB, Dash AP. Nina PB, et al. Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20. Indian J Public Health. 2020. PMID: 32496241 Free article. Review.
Hydroxychloroquine (HCQ), an antimalarial has been proposed as possible treatment for coronavirus disease-2019 (COVID-19). India has approved the use of HCQ for prophylaxis of asymptomatic health workers treating suspected or confirmed COVID
Hydroxychloroquine (HCQ), an antimalarial has been proposed as possible treatment for coronavirus disease-2019 (COVI
Chloroquine as a prophylactic agent against COVID-19?
Gendrot M, Javelle E, Clerc A, Savini H, Pradines B. Gendrot M, et al. Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12. Int J Antimicrob Agents. 2020. PMID: 32294495 Free PMC article.
• Efficacy of chloroquine and hydroxychloroquine in COVID-19 treatment is discussed. • Prophylactic use of chloroquine or hydroxychloroquine in COVID-19 is considered....
• Efficacy of chloroquine and hydroxychloroquine in COVID-19 treatment is discussed. • Prophylactic use of ch
Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
Popescu CP, Fischer PR. Popescu CP, et al. Travel Med Infect Dis. 2020 May-Jun;35:101764. doi: 10.1016/j.tmaid.2020.101764. Epub 2020 May 30. Travel Med Infect Dis. 2020. PMID: 32485391 Free PMC article. No abstract available.
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings.
Abena PM, Decloedt EH, Bottieau E, Suleman F, Adejumo P, Sam-Agudu NA, Muyembe TamFum JJ, Seydi M, Eholie SP, Mills EJ, Kallay O, Zumla A, Nachega JB. Abena PM, et al. Am J Trop Med Hyg. 2020 Jun;102(6):1184-1188. doi: 10.4269/ajtmh.20-0290. Am J Trop Med Hyg. 2020. PMID: 32323646 Free PMC article.
The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nearly all countries have reported laboratory-confirmed cases of novel coronavirus disease (COVID-19). ...Chloroquine
The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nea …
Hydroxychloroquine/ chloroquine as a treatment choice or prophylaxis for Covid-19 at the primary care level in developing countries: A Primum non Nocere dilemma.
Chevalier MTM, Moncada SS. Chevalier MTM, et al. J Neurol Sci. 2020 Jun 3;415:116972. doi: 10.1016/j.jns.2020.116972. Online ahead of print. J Neurol Sci. 2020. PMID: 32534369
The Food and Drug Administration (FDA) warned against the use of Hydroxychloroquine or chloroquine for Covid-19 outside of a hospital or a clinical trial setting due to the risk of QT interval prolongation, ventricular tachycardia and the increased ris …
The Food and Drug Administration (FDA) warned against the use of Hydroxychloroquine or chloroquine for Covid-19
Antiviral treatment of COVID-19.
Şimşek Yavuz S, Ünal S. Şimşek Yavuz S, et al. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Turk J Med Sci. 2020. PMID: 32293834 Free PMC article. Review.
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most of the COVID-19 patients have mild or moderate courses, up to 5%–10% can have severe, potentially life threatening course, there is an urgent need for …
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most of the COVID-19 p …
COVID-19 and neuromuscular disorders.
Guidon AC, Amato AA. Guidon AC, et al. Neurology. 2020 Jun 2;94(22):959-969. doi: 10.1212/WNL.0000000000009566. Epub 2020 Apr 13. Neurology. 2020. PMID: 32284362 Review.
The coronavirus 2019 (COVID-19) pandemic has potential to disproportionately and severely affect patients with neuromuscular disorders. ...This article reviews (1) potential neuromuscular complications of COVID-19, (2) assessment a …
The coronavirus 2019 (COVID-19) pandemic has potential to disproportionately and severely affect patients with n …
56 results
Jump to page
Feedback